Pages that link to "Q77333693"
Jump to navigation
Jump to search
The following pages link to Clinical applications of anticancer drugs targeted to topoisomerase II (Q77333693):
Displaying 50 items.
- Modulation of human DNA topoisomerase IIalpha function by interaction with 14-3-3epsilon (Q22254010) (← links)
- RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression (Q24293748) (← links)
- The ATP-operated clamp of human DNA topoisomerase IIalpha: hyperstimulation of ATPase by "piggy-back" binding (Q24300110) (← links)
- (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases (Q24627296) (← links)
- Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement (Q24642324) (← links)
- Induction of unique structural changes in guanine-rich DNA regions by the triazoloacridone C-1305, a topoisomerase II inhibitor with antitumor activities (Q24811057) (← links)
- Structural basis for gate-DNA recognition and bending by type IIA topoisomerases (Q27649385) (← links)
- Targeting mRNA for Alzheimer's and related dementias. (Q27687153) (← links)
- A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response (Q28539430) (← links)
- Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression (Q29615223) (← links)
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin (Q30540353) (← links)
- Purification of GidA protein, a novel topoisomerase II inhibitor produced by Streptomyces flavoviridis. (Q31136132) (← links)
- Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue (Q33398170) (← links)
- Influence of cell cycle and oncogene activity upon topoisomerase IIalpha expression and drug toxicity (Q33606082) (← links)
- Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions (Q33631024) (← links)
- Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231 (Q33647335) (← links)
- Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice (Q33851826) (← links)
- Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme. (Q33922870) (← links)
- NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells (Q34459467) (← links)
- Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells (Q34514751) (← links)
- The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I (Q34559593) (← links)
- Culprit and victim -- DNA topoisomerase II. (Q34688577) (← links)
- Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer (Q34895090) (← links)
- Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage (Q34909651) (← links)
- Contributions of the D-Ring to the activity of etoposide against human topoisomerase IIα: potential interactions with DNA in the ternary enzyme--drug--DNA complex. (Q35030777) (← links)
- Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks (Q35222177) (← links)
- Rapid Identification of Chemoresistance Mechanisms Using Yeast DNA Mismatch Repair Mutants (Q35704726) (← links)
- Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression. (Q35770478) (← links)
- Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse (Q36065491) (← links)
- Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II. (Q36136076) (← links)
- Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung Cancer (Q36394224) (← links)
- The role of chemotherapy in the treatment of malignant astrocytomas (Q36493495) (← links)
- Cancer cell response to anthracyclines effects: mysteries of the hidden proteins associated with these drugs (Q36538243) (← links)
- Coupling between ATP binding and DNA cleavage by DNA topoisomerase II: A unifying kinetic and structural mechanism. (Q36719248) (← links)
- The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs (Q36839637) (← links)
- DNA topoisomerase II, genotoxicity, and cancer (Q36903197) (← links)
- Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme (Q37184017) (← links)
- Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy (Q37207935) (← links)
- Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity. (Q37332317) (← links)
- Metnase mediates chromosome decatenation in acute leukemia cells (Q37334609) (← links)
- Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions. (Q37407949) (← links)
- DNA repair in Etoposide-induced DNA damage in lymphocytes of breast cancer patients and healthy women (Q37412567) (← links)
- Phenanthriplatin Acts As a Covalent Poison of Topoisomerase II Cleavage Complexes (Q37596167) (← links)
- Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons (Q37658182) (← links)
- MYC in oncogenesis and as a target for cancer therapies (Q37732974) (← links)
- Human topoisomerase IIalpha possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5' covalently activated oligonucleotide substrates to study enzyme mechanism (Q38288542) (← links)
- Base excision repair intermediates as topoisomerase II poisons (Q38295973) (← links)
- A two-drug model for etoposide action against human topoisomerase IIalpha (Q38359958) (← links)
- High-throughput assays for DNA gyrase and other topoisomerases (Q38756222) (← links)
- Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models (Q38962673) (← links)